D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 57 Citations 10,590 131 World Ranking 1409 National Ranking 99

Overview

What is she best known for?

The fields of study she is best known for:

  • Gene
  • Virus
  • Immune system

Mirjam B. Zeisel spends much of her time researching Hepatitis C virus, Virology, Viral entry, Virus and CD81. The Hepatitis C virus study combines topics in areas such as Liver disease and Tissue tropism. Mirjam B. Zeisel focuses mostly in the field of Liver disease, narrowing it down to topics relating to Hepatitis B virus and, in certain cases, Cancer research.

Her Virology research integrates issues from Antibody, Immunology and Epidermal growth factor receptor. Her Viral entry research includes themes of Tyrosine kinase, EPH receptor A2, Kinase activity and Erythropoietin-producing hepatocellular receptor. As part of the same scientific family, Mirjam B. Zeisel usually focuses on Virus, concentrating on Epitope and intersecting with Viral replication, Hypervariable region, Infectivity and Molecular biology.

Her most cited work include:

  • EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy (535 citations)
  • EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy (535 citations)
  • Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C (430 citations)

What are the main themes of her work throughout her whole career to date?

Her main research concerns Virology, Hepatitis C virus, Immunology, Virus and Viral entry. Her study in Virology is interdisciplinary in nature, drawing from both Antibody and Monoclonal antibody. Her work deals with themes such as Cell culture, Pathogenesis, Immune system, Liver disease and Hepatocellular carcinoma, which intersect with Hepatitis C virus.

Her Immunology study combines topics in areas such as Chronic liver disease and Liver transplantation. Her work carried out in the field of Virus brings together such families of science as Epitope and Interferon. Her work in Viral entry tackles topics such as Scavenger receptor which are related to areas like Receptor.

She most often published in these fields:

  • Virology (107.32%)
  • Hepatitis C virus (98.54%)
  • Immunology (54.63%)

What were the highlights of her more recent work (between 2017-2021)?

  • Liver disease (39.02%)
  • Hepatocellular carcinoma (35.12%)
  • Hepatitis C virus (98.54%)

In recent papers she was focusing on the following fields of study:

Her primary areas of investigation include Liver disease, Hepatocellular carcinoma, Hepatitis C virus, Virology and Virus. Her Liver disease research is multidisciplinary, incorporating elements of Regulation of gene expression, Tight junction and Disease. Mirjam B. Zeisel combines subjects such as Cirrhosis and Epigenetics with her study of Hepatocellular carcinoma.

Her Hepatitis C virus study frequently draws parallels with other fields, such as microRNA. Her Virus research is multidisciplinary, incorporating perspectives in Interferon, Innate immune system and Cell culture. Her Viral entry research includes elements of Chronic infection and Immune system.

Between 2017 and 2021, her most popular works were:

  • HCV-Induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic Response. (68 citations)
  • HCV-Induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic Response. (68 citations)
  • HCV-Induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic Response. (68 citations)

In her most recent research, the most cited papers focused on:

  • Gene
  • Virus
  • Cancer

The scientist’s investigation covers issues in Liver disease, Hepatocellular carcinoma, Cancer research, Cirrhosis and Virus. Her biological study spans a wide range of topics, including Cancer, Viral entry and Evasion, Immune system. The various areas that she examines in her Hepatocellular carcinoma study include Hepatitis C virus, Downregulation and upregulation, microRNA, Fibrosis and STAT3.

Her work carried out in the field of Hepatitis C virus brings together such families of science as Peroxisome proliferator-activated receptor, Transcriptome, Antibody and Steatohepatitis, Fatty liver. Her biological study spans a wide range of topics, including Pathogenesis, Receptor, Disease, Regulation of gene expression and Tight junction. Her Virus study is concerned with the field of Immunology as a whole.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy

Joachim Lupberger;Mirjam B Zeisel;Mirjam B Zeisel;Fei Xiao;Fei Xiao;Christine Thumann;Christine Thumann.
Nature Medicine (2011)

706 Citations

Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C

Jan M. Pestka;Mirjam B. Zeisel;Edith Bläser;Peter Schürmann.
Proceedings of the National Academy of Sciences of the United States of America (2007)

570 Citations

miR-122 – A key factor and therapeutic target in liver disease

Simonetta Bandiera;Simonetta Bandiera;Sébastien Pfeffer;Sébastien Pfeffer;Thomas F. Baumert;Thomas F. Baumert;Mirjam B. Zeisel;Mirjam B. Zeisel.
Journal of Hepatology (2015)

404 Citations

Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81

Mirjam B. Zeisel;Mirjam B. Zeisel;George Koutsoudakis;Eva K. Schnober;Anita Haberstroh;Anita Haberstroh.
Hepatology (2007)

334 Citations

Apolipoprotein E interacts with hepatitis C virus nonstructural protein 5A and determines assembly of infectious particles.

Wagane J. A. Benga;Wagane J. A. Benga;Sophie E. Krieger;Sophie E. Krieger;Maria Dimitrova;Maria Dimitrova;Mirjam B. Zeisel;Mirjam B. Zeisel.
Hepatology (2010)

244 Citations

Towards an HBV cure: state-of-the-art and unresolved questions—report of the ANRS workshop on HBV cure

Mirjam B. Zeisel;Julie Lucifora;William S. Mason;Camille Sureau.
Gut (2015)

238 Citations

Hepatitis C Virus Hypervariable Region 1 Modulates Receptor Interactions, Conceals the CD81 Binding Site, and Protects Conserved Neutralizing Epitopes

Dorothea Bankwitz;Eike Steinmann;Julia Bitzegeio;Sandra Ciesek.
Journal of Virology (2010)

236 Citations

Hepatitis C virus entry into hepatocytes: molecular mechanisms and targets for antiviral therapies.

Mirjam B. Zeisel;Mirjam B. Zeisel;Isabel Fofana;Isabel Fofana;Samira Fafi-Kremer;Samira Fafi-Kremer;Thomas F. Baumert;Thomas F. Baumert.
Journal of Hepatology (2011)

233 Citations

Inhibition of hepatitis C virus infection by anti-claudin-1 antibodies is mediated by neutralization of E2-CD81-claudin-1 associations.

Sophie E. Krieger;Mirjam B. Zeisel;Mirjam B. Zeisel;Christopher Davis;Christine Thumann;Christine Thumann.
Hepatology (2010)

219 Citations

HRas Signal Transduction Promotes Hepatitis C Virus Cell Entry by Triggering Assembly of the Host Tetraspanin Receptor Complex

Laetitia Zona;Joachim Lupberger;Joachim Lupberger;Nazha Sidahmed-Adrar;Nazha Sidahmed-Adrar;Christine Thumann;Christine Thumann.
Cell Host & Microbe (2013)

195 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Mirjam B. Zeisel

Thomas F. Baumert

Thomas F. Baumert

University of Strasbourg

Publications: 154

Jens Bukh

Jens Bukh

University of Copenhagen

Publications: 62

Thomas Pietschmann

Thomas Pietschmann

Hannover Medical School

Publications: 58

Ralf Bartenschlager

Ralf Bartenschlager

Heidelberg University

Publications: 55

Jane A. McKeating

Jane A. McKeating

University of Oxford

Publications: 55

Takaji Wakita

Takaji Wakita

National Institutes of Health

Publications: 52

Fabien Zoulim

Fabien Zoulim

Inserm : Institut national de la santé et de la recherche médicale

Publications: 52

Jean Dubuisson

Jean Dubuisson

Institut Pasteur

Publications: 48

Steven K. H. Foung

Steven K. H. Foung

Stanford University

Publications: 44

François-Loïc Cosset

François-Loïc Cosset

Claude Bernard University Lyon 1

Publications: 43

Alexander Ploss

Alexander Ploss

Princeton University

Publications: 42

Heidi E. Drummer

Heidi E. Drummer

Burnet Institute

Publications: 38

Charles M. Rice

Charles M. Rice

Rockefeller University

Publications: 37

Koichi Watashi

Koichi Watashi

National Institutes of Health

Publications: 36

Arvind H. Patel

Arvind H. Patel

University of Glasgow

Publications: 35

Philip Meuleman

Philip Meuleman

Ghent University

Publications: 33

Trending Scientists

Rasmus Larsen

Rasmus Larsen

Technical University of Denmark

Riccardo Chirone

Riccardo Chirone

National Academies of Sciences, Engineering, and Medicine

Mark Lawley

Mark Lawley

Texas A&M University

Beno Benhabib

Beno Benhabib

University of Toronto

Herbert van Amerongen

Herbert van Amerongen

Wageningen University & Research

Roy A. Norton

Roy A. Norton

State University of New York

Yuri A. Trotsenko

Yuri A. Trotsenko

Russian Academy of Sciences

Esther van der Knaap

Esther van der Knaap

University of Georgia

Olivier Rieppel

Olivier Rieppel

Field Museum of Natural History

Jacques Locat

Jacques Locat

Université Laval

Malte Meinshausen

Malte Meinshausen

University of Melbourne

Bruce H. Vaughn

Bruce H. Vaughn

Institute of Arctic and Alpine Research

Roger S. Blumenthal

Roger S. Blumenthal

Johns Hopkins University

David W. Murray

David W. Murray

University of Oxford

Klaus Armingeon

Klaus Armingeon

University of Bern

Dimitar Sasselov

Dimitar Sasselov

Harvard University

Something went wrong. Please try again later.